Search results for "herpes"

showing 10 items of 307 documents

Detection of Epstein-Barr virus (EBV) DNA and antigens in oral mucosa of renal transplant patients without clinical evidence of oral hairy leukoplaki…

1998

The use of the polymerase chain reaction (PCR) to detect the presence of Epstein-Barr virus (EBV) DNA in oral mucosa in the absence of specific lesions gives rise to the problem of identifying the real viral replication sites. To verify whether the detection of EBV is due to salivary contamination or its true replicative capacity in oral mucosa, saliva samples and exfoliated cells from four different oral mucosa sites were taken from 40 renal transplant patients and 20 normal subjects for examination by PCR using two pairs of primers specific for the BamHI-L and BamHI-K genomic regions. EBV-specific sequences were detected in one or more of the oral mucosa samples from 29 transplant patient…

AdultMaleHairy leukoplakiaHerpesvirus 4 HumanCancer ResearchPathologymedicine.medical_specialtySalivaLeukoplakia HairyAdolescentCD4-CD8 RatioFluorescent Antibody TechniqueGenome ViralBiologyVirus Replicationmedicine.disease_causePolymerase Chain ReactionHerpesviridaePathology and Forensic Medicinelaw.inventionImmunocompromised HostlawmedicineHumansOral mucosaSalivaAntigens ViralIn Situ HybridizationPolymerase chain reactionOral hairy leukoplakiaMouth MucosaAntibodies MonoclonalHLA-DR AntigensSequence Analysis DNAMiddle Agedmedicine.diseaseKidney TransplantationEpstein–Barr virusImmunoglobulin ATransplantationBlotting Southernmedicine.anatomical_structureOtorhinolaryngologyImmunoglobulin GDNA ViralImmunologyPeriodonticsFemaleOral SurgeryJournal of Oral Pathology & Medicine
researchProduct

The epidemiology of Varicella Zoster Virus infection in Italy

2008

Abstract Background The epidemiological importance of varicella and zoster and the availability of an efficacious and safe vaccine have led to an important international debate regarding the suitability of mass vaccination. The objective of the study was to describe the epidemiology of varicella and zoster in Italy and to determine whether there have been changes with respect to observations provided by an analogous study conducted 8 years ago, in order to define the most appropriate vaccination strategy. Methods A number of data sources were evaluated, a cross-sectional population-based seroprevalence study was conducted on samples collected in 2004, and the results were compared with data…

AdultMaleHerpesvirus 3 HumanSettore MED/07 - Microbiologia E Microbiologia ClinicaPediatricsmedicine.medical_specialtyAdolescentCross-sectional studyPopulationVaricellamedicine.disease_causeYoung AdultChickenpoxSeroepidemiologic StudiesEnvironmental healthEpidemiologymedicineHumansSeroprevalencePreschoolChildeducationVaricella Zosterepidemiology infection in Italyeducation.field_of_studyChickenpoxbusiness.industrylcsh:Public aspects of medicineHerpesvirus 3Infant NewbornPublic Health Environmental and Occupational HealthVaricella zoster virusInfantvirus diseaseslcsh:RA1-1270Middle AgedNewbornmedicine.diseaseVaccinationCross-Sectional StudiesItalyInfectious disease (medical specialty)Adolescent; Adult; Chickenpox; Child; Child Preschool; Cross-Sectional Studies; Female; Herpesvirus 3 Human; Humans; Infant; Infant Newborn; Italy; Male; Middle Aged; Seroepidemiologic Studies; Young AdultChild PreschoolFemalebusinessHumanResearch ArticleBMC Public Health
researchProduct

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical tr…

2019

BACKGROUND: The adjuvanted recombinant zoster vaccine (Shingrix) can prevent herpes zoster in older adults and autologous haemopoietic stem cell transplant recipients. We evaluated the safety and immunogenicity of this vaccine in adults with haematological malignancies receiving immunosuppressive cancer treatments. METHODS: In this phase 3, randomised, observer-blind, placebo-controlled study, done at 77 centres worldwide, we randomly assigned (1:1) patients with haematological malignancies aged 18 years and older to receive two doses of the adjuvanted recombinant zoster vaccine or placebo 1-2 months apart during or after immunosuppressive cancer treatments, and stratified participants acco…

AdultMaleHerpesvirus 3 Humanmedicine.medical_specialtyAdolescentPopulationAntineoplastic AgentsAntibodies ViralPlaceboHematological malignanciesImmunocompromised HostYoung Adult03 medical and health sciences0302 clinical medicineViral Envelope ProteinsInternal medicinemedicineHerpes Zoster VaccineHumansSingle-Blind Method030212 general & internal medicineeducationAdverse effectFatigueImmunity CellularVaccines Syntheticeducation.field_of_studyVaccinesReactogenicityH. Zosterbusiness.industryImmunogenicityMiddle AgedCD4 Lymphocyte CountInjection Site ReactionVaccinationClinical trialInfectious DiseasesHematologic Neoplasms030220 oncology & carcinogenesisH. Zoster; Vaccines; Hematological malignanciesFemaleZoster vaccinebusinessVaccinemedicine.drug
researchProduct

Acyclovir treatment in 2 patients with benign trigeminal sensory neuropathy

2001

AdultMaleHerpesvirus 3 Humanmedicine.medical_specialtymedicine.medical_treatmentAcyclovirAdministration OralNeurological disorderAntibodies ViralAntiviral AgentsHypesthesiamedicineHumansSimplexvirusAciclovirTrigeminal nerveChemotherapybusiness.industryAcyclic nucleosideHypoesthesiamedicine.diseaseDermatologySurgeryPeripheral neuropathyOtorhinolaryngologyTrigeminal Nerve DiseasesImmunoglobulin GSensory neuropathyFemaleSurgeryOral Surgerymedicine.symptombusinessFollow-Up Studiesmedicine.drugJournal of Oral and Maxillofacial Surgery
researchProduct

PREDICTION OF SEVERE RHEUMATOID ARTHRITIS USING EPSTEIN-BARR VIRUS

1994

One of the immunological abnormalities in patients with RA is increased synthesis of immunoglobulins (Ig) in cultures of Epstein-Barr virus (EBV-) stimulated lymphocytes. We set out to investigate whether this feature, seen early in the disease, associated with later severe RA. We studied prospectively 45 patients with recent onset RA and, 41 healthy individuals. From 0-6 months after admission, blood lymphocytes were cultured in the presence of EBV for 4 weeks and Ig in the supernatants were assayed. To assess the severity of disease, clinical, laboratory and radiological evaluations were performed every 6 months for 2 yr. The association of increased Ig production with the severity of RA …

AdultMaleHerpesvirus 4 HumanAdolescentLymphocyteDiseaseAntibodies Viralmedicine.disease_causeSeverity of Illness IndexHerpesviridaeArthritis RheumatoidRheumatologyPredictive Value of TestsSeverity of illnessHumansMedicinePharmacology (medical)LymphocytesProspective StudiesProspective cohort studyAgedAutoimmune diseaseArthritis Infectiousbiologybusiness.industryHerpesviridae InfectionsMiddle Agedmedicine.diseasemedicine.anatomical_structureRheumatoid arthritisImmunologybiology.proteinFemaleAntibodybusinessRheumatology
researchProduct

Epstein Barr Virus detection and latent membrane protein 1 in oral hairy leukoplakia in HIV+ Venezuelan patients

2008

Purpose: To determine the prevalence of Epstein Barr Virus (EBV) in oral hairy leukoplakia lesions (OHL) in HIV+ Venezuelan patients. Material and Method: In this case study, we evaluated 21 HIV+ adult patients with clinically present OHL lesions, 11 who were undergoing antiretroviral therapy, 10 who were not undergoing therapy and 10 HIV-negative adult patients with hyperkeratotic oral mucosal lesions. All of the subjects were assessed at the Infectious Disease Center, Faculty of Dentistry, Central University of Venezuela, and were clinically examined to detect oral mucosal lesions with the confirmed histopathologic diagnosis. Nested-PCR was used to determine the EBV infection and the late…

AdultMaleHerpesvirus 4 HumanLeukoplakia HairyHuman immunodeficiency virus (HIV)medicine.disease_causeViral Matrix ProteinsYoung Adulthemic and lymphatic diseasesHIV SeropositivityHumansMedicineYoung adultGeneral DentistryLeukoplakiaOral hairy leukoplakiabusiness.industryMiddle AgedVenezuela:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseAntiretroviral therapyEpstein–Barr virusOtorhinolaryngologyInfectious disease (medical specialty)UNESCO::CIENCIAS MÉDICASImmunologyImmunohistochemistryFemaleSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

2020

ObjectiveTo determine the prevalence of antibodies to Epstein-Barr virus (EBV) in a large cohort of patients with early multiple sclerosis (MS).MethodsSerum samples were collected from 901 patients with a clinically isolated syndrome (CIS) or early relapsing–remitting multiple sclerosis (RRMS) participating in the German National MS cohort, a prospective cohort of patients with early MS with stringent inclusion criteria. Epstein-Barr nuclear antigen (EBNA)-1 and viral capsid antigen (VCA) antibodies were measured in diluted sera by chemiluminescence immunoassays (CLIAs). Sera of EBNA-1 and VCA antibody-negative patients were retested undiluted by an EBV IgG immunoblot. For comparison, we re…

AdultMaleHerpesvirus 4 HumanMultiple Sclerosis610 Medicine & healthmedicine.disease_causeAntibodies ViralSerology03 medical and health sciences0302 clinical medicineAntigenSeroepidemiologic Studieshemic and lymphatic diseasesGermanymedicineSeroprevalenceHumans1506Registriesddc:610Prospective cohort study610 Medicine & health030304 developmental biologyRetrospective Studies0303 health sciencesClinically isolated syndromebusiness.industryMultiple sclerosisMiddle Agedmedicine.diseaseEpstein–Barr virusddc:Psychiatry and Mental healthImmunologyCohortSurgeryFemaleNeurology (clinical)Function and Dysfunction of the Nervous Systembusiness030217 neurology & neurosurgery
researchProduct

Epstein-Barr virus is not detected in mucosal lichen planus

2018

Background Lichen planus (LP) is a chronic inflammatory, immunological, mucocutaneous disease can affect skin, genital and oral mucosa. Oral lichen planus (OLP) is the most common noninfectious, chronic inflammatory oral disease affecting 1-2% of the general adult population. World Health Organization (WHO) classifies OLP as a potentially malignant disorder. Epstein Barr virus or human herpesvirus-4, is a member of the herpes virus family and one of the most ubiquitous viruses known to human, infecting approximately 90% of the world’s adult population. The virus often infects B lymphocytes resulting in a wide spectrum of mucocutaneous and systemic diseases, ranging from mild lesions to aggr…

AdultMaleHerpesvirus 4 Humanmedicine.medical_specialtyMucocutaneous zonemedicine.disease_causeYoung Adult03 medical and health sciences0302 clinical medicinestomatognathic systemmedicineHumansSex organOral mucosaskin and connective tissue diseasesGeneral DentistryAgedAged 80 and overOral Medicine and PathologyMucous Membraneintegumentary systembusiness.industryResearchLichen Planusfood and beveragesMucous membrane030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseEpstein–Barr virusDermatologystomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASFemaleSurgeryOral lichen planusbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease

1998

Human cytomegalovirus (HCMV)-specific antibody responses in HIV-1 infected individuals either with or without HCMV end-organ disease were examined to determine the whether development of HCMV disease was associated with a particular deficit in the antibody response. Antiwhole HCMV, anti-glycoprotein B (gB), and neutralizing antibody levels were higher in HIV-1 infected individuals than in healthy immunocompetent subjects, particularly in patients with AIDS either with or without HCMV-associated disease. Irrespective of location and spread of HCMV disease, patients who had received anti-HCMV therapy prior to sampling exhibited significantly higher anti-gB and neutralizing antibody titers tha…

AdultMaleHuman cytomegalovirusAdolescentvirusesCytomegalovirusBiologyAntibodies ViralAntiviral AgentsViral Envelope ProteinsNeutralization TestsBetaherpesvirinaeVirologyImmunopathologymedicineHumansViremiaFluorescent Antibody Technique IndirectNeutralizing antibodyAcquired Immunodeficiency SyndromeAIDS-Related Opportunistic InfectionsAntibody titervirus diseasesbiochemical phenomena metabolism and nutritionmedicine.diseasebiology.organism_classificationVirologyCD4 Lymphocyte CountInfectious DiseasesImmunoglobulin GCytomegalovirus InfectionsImmunologyHIV-1biology.proteinFemaleViral diseaseAntibodyViral loadJournal of Medical Virology
researchProduct

Quantification of DNA in Plasma by an Automated Real-Time PCR Assay (Cytomegalovirus PCR Kit) for Surveillance of Active Cytomegalovirus Infection an…

2008

ABSTRACT The performance of a plasma real-time PCR (cytomegalovirus [CMV] PCR kit; Abbott Diagnostics) was compared with that of the antigenemia assay for the surveillance of active CMV infection in 42 allogeneic hematopoietic stem cell transplantation (Allo-SCT) recipients. A total of 1,156 samples were analyzed by the two assays. Concordance between the two assays was 82.2%. Plasma DNA levels correlated with the number of pp65-positive cells, particularly prior to the initiation of preemptive therapy. Fifty-seven episodes of active CMV infection were detected in 37 patients: 18 were defined solely by the PCR assay and four were defined on the basis of the antigenemia assay. Either a cutof…

AdultMaleMicrobiology (medical)Adolescentmedicine.medical_treatmentCongenital cytomegalovirus infectionCytomegalovirusHematopoietic stem cell transplantationmedicine.disease_causeAntiviral AgentsChemopreventionPolymerase Chain ReactionSensitivity and SpecificityHerpesviridaelaw.inventionViral Matrix ProteinsPlasmalawBetaherpesvirinaeVirologymedicineHumansAntigens ViralPolymerase chain reactionAgedbiologyHematopoietic Stem Cell Transplantationvirus diseasesMiddle AgedViral LoadPhosphoproteinsmedicine.diseasebiology.organism_classificationVirologyReal-time polymerase chain reactionROC CurveCytomegalovirus InfectionsDNA ViralImmunologyFemaleViral diseaseViral loadJournal of Clinical Microbiology
researchProduct